Indoco Remedies Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹475.61 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.79 per cent from ₹445.36 crore. This corresponds to a year-on-year *(YoY) growth of 21.89 per cent.
Operating Profit
Operating Profit stands at ₹49.71 crore, reflecting a quarter-on-quarter *(QoQ) increase of 96.02 per cent from ₹25.36 crore. This corresponds to a year-on-year *(YoY) growth of 6,473.08 per cent.
PBDT
PBDT stands at ₹7.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 970.00 per cent from ₹0.70 crore. This corresponds to a year-on-year *(YoY) growth of 144.74 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-25.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.15 per cent from ₹-31.31 crore. This corresponds to a year-on-year *(YoY) growth of 45.08 per cent.
Net Profit
Net Profit stands at ₹-23.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.59 per cent from ₹-29.45 crore. This represents a 42.72 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd News
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | 2.17% | 10.70% | 4.92% | 24.41% | 21.49% | -18.20% |
| Solara Active | 1.41% | 1.96% | -6.24% | 16.96% | 3.63% | -15.36% |
| Kwality Pharma | -0.79% | -1.47% | 4.69% | 74.39% | 138.69% | 122.31% |
| Sai Parenteral's | -1.18% | -3.80% | 3.54% | 37.51% | 44.50% | 44.50% |
| Venus Remedies | 0.41% | 3.14% | -4.68% | 65.10% | 142.17% | 260.71% |
| Ind-Swift Labs. | 4.54% | 11.14% | 51.26% | 76.88% | 170.89% | 131.36% |
| NGL Fine Chem | 0.40% | -0.95% | 4.51% | 42.81% | 121.57% | 144.78% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Non-Exec & Non-Independent Dir : Anand Nadkarni
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN